Interpleural morphine vs bupivacaine for postthoracotomy pain relief

Area of Science:

• Anesthesiology
• Pain Management
• Thoracic Surgery

Background:

• Postthoracotomy pain is a significant clinical challenge.
• Effective pain management is crucial for patient recovery and reducing complications.
• Interpleural regional anesthesia is a common technique for managing this pain.

Purpose of the Study:

• To compare the efficacy of interpleural bupivacaine versus interpleural morphine for postthoracotomy pain control.
• To evaluate analgesic effects, supplementary analgesic requirements, and side effects.

Main Methods:

• Prospective, randomized, double-blind trial involving 36 patients undergoing posterolateral thoracotomy.
• Patients received either interpleural bupivacaine or morphine for 24 hours post-surgery.
• Pain severity assessed using a visual analog scale (VAS) at rest and on coughing.

Main Results:

• Both interpleural morphine and bupivacaine significantly reduced pain scores post-injection.
• Patients receiving interpleural morphine reported significantly lower pain scores.
• The interpleural morphine group required significantly less supplementary intravenous analgesia.

Conclusions:

• Interpleural morphine provides superior postthoracotomy pain management compared to interpleural bupivacaine.
• Morphine offers better analgesia with no increase in serious adverse events.
• This suggests morphine is a more effective agent for interpleural administration in this setting.